Company Overview

Symphony Health is a wholly owned subsidiary of PRA Health Sciences, which is a publicly traded company on NASDAQ: PRAH. Symphony Health was acquired by PRA Health Sciences in August 2017 from Symphony Technology Group. Symphony Health Solutions has 270 employees.  PRA’s global clinical development platform includes more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and over 16,000 employees worldwide. 5% of Symphony Health resources are actively involved with measurement and lift engagements.

Data Collection Methodology

Symphony’s Integrated Dataverse captures healthcare transactions on 280 million people annually. By transaction type this breaks down as follows:

• Dispensed Pharmacy Transactions, Retail: 81%
• Dispensed Pharmacy Transactions, Mail Order: 60%
• Dispensed Pharmacy Transactions, Specialty: ~65% (varies by Brand and Distribution channels)
• Professional Service Claims: 60%
• Institutional (Hospital) Claims: 25%

Types of Data Sets Available

Doctor Office visits, Doctor Specialty. New to Rx, Rx, New Diagnosis and Dx. Electronic Medical records, Data from Adjudicator and large pharmacy partners as well as Lab data.